By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    headphones can create health problems
    The Harmful Health Effects of Using Headphones
    September 24, 2021
    Headache causes
    4 Causes Of Headache You Probably Didn’t Know About
    December 28, 2021
    follow these steps to recover from your injury
    What Steps Should You Take to Recover More Quickly from an Injury?
    April 12, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Recognizing When You Are Enabling A Person Struggling with Addiction
    February 5, 2021
    Contraception for Techno-Doctors
    July 13, 2011
    ACP Ethics Manual on Social Media, Catastrophes, and More
    January 13, 2012
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: SAS and GSK Pull Big Pharma Into Big Data Collaboration
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > SAS and GSK Pull Big Pharma Into Big Data Collaboration
BusinesseHealthNews

SAS and GSK Pull Big Pharma Into Big Data Collaboration

Dan Munro
Dan Munro
Share
6 Min Read
Big Pharma
SHARE

(Editor’s Note: Dan Munro writes for Forbes under the heading HealthCare Compass)

(Editor’s Note: Dan Munro writes for Forbes under the heading HealthCare Compass)

Of all the companies that specialize in big data analytics, the real pioneer (at scale) has always been SAS – headquartered in Cary, North Carolina. Earlier today, in a big, bold bet on moving one of the larger needles in healthcare, SAS announced a collaborative effort with drug giant GlaxoSmithKline aimed squarely at the global pharmaceutical industry.

In a nutshell, SAS is sponsoring the ongoing support and management of a globally accessible private cloud where the pharmaceutical industry can securely collaborate around anonymized clinical trial information. GSK has made the bold commitment to be the first to contribute anonymized clinical trial data.Big Pharma

More Read

The Fallacy of Patient Engagement
Social Media Policies and “Spying” by Physicians
Americans Pay Far More for Medications Than Anywhere in the World
Digital Marketing Best Practices for Vein Clinics
How Much Weight Can You Lose in a Month?

In development over the last two months, the SAS-led initiative started with GSK (one of the world’s Top Ten pharmaceutical companies), but quickly led to discussions with other big pharma companies who will likely join – and benefit – from an entirely new private cloud for clinical trial information globally.

As more companies sign on, the potential scale of the pooled clinical trial data is unprecedented – especially for an industry that is often cloaked in controversy or mired in headlines announcing billion dollar fines.

Not surprisingly, the press release (here) was strategically aimed to coincide with the Drug Information Association’s 49th Annual Meeting being held this week in Boston (here). The organization (known simply as DIA) was founded in 1964 and has served as:

“… a neutral, global, nonprofit association that provides professionals at all levels and across all disciplines access to timely and authoritative information to advance career skills and innovation in the pharmaceutical, biotechnology, medical device and related fields.” DIA website

For the healthcare industry globally (and big pharma specifically), this one has the potential to be a big data (and cloud technology) blockbuster.

“Liberating this data will help advance scientific understanding and empower the scientific community to learn from the research and more quickly and effectively improve care for patients with all kinds of diseases and disorders, from diabetes to ADHD. The value has the potential to be greatly enhanced as researchers are able to gain access to data from multiple companies through a single site.” Matt Gross, Business Director, SAS Health and Life Sciences

“This movement toward transparency is part of a larger industry trend and we’re in discussions with other pharma organizations that also plan to publish their data to a broader system where researchers and others are able to access the information from clinical trials conducted by multiple companies.” Graham Hughes, MD, Chief Medical Officer, SAS Center for Health Analytics and Insights

The use of the word “liberating” struck me as a reminder to Todd Park’s clarion call and personal crusade which he often delivers with great animation during presentations – where he’ll often shout his signature phrase “Data Liberacion!”

The GSK quote was equally compelling:

“In sharing our data with researchers around the world, we hope to further scientific research and increase understanding about our medicines. Our goal is to see this initiative transition to a broader system allowing researchers to access data from trials conducted by multiple organizations. Our belief is that this is the right thing to do for our industry and society – so let’s get started.” Perry Nisen, GlaxoSmithKline Senior Vice President for Science and Innovation

GSK’s foundational and pioneering commitment to making anonymized clinical trial data available to the industry was announced last October (here) with a follow-on announcement last month (here).

While the scale and scope of this private cloud initiative is new, the depth and breadth of healthcare leadership at SAS clearly isn’t. Earlier this year, the company hosted their 10th annual SAS Health Care & Life Sciences Executive Conference (here) and this is now the second high profile collaboration by SAS with big pharma around big data and analytics. The first one is Project Data Sphere – an initiative led by the CEO Roundtable on Cancer’s Life Sciences Consortium. An excellent overview of this initiative (and deep commitment) is made in this 6 minute video by Charles Hugh-Jones – Chief Medical Officer at Sanofi (as a representative of the Life Sciences Consortium).

Recognizing the critical nature – and huge business value – of big data, SAS was founded over 30 years ago by a team of North Carolina State University colleagues led by Dr. James Goodnight (Forbes Billionaire #154). SAS remains one of the icons in the software industry and has recorded annual revenue growth for each year since its inception in 1976.

The reality, of course, is that any of these collaborative efforts by big pharma will likely take years to produce tangible clinical results. They often do. But there were also some seismic takeaways from today’s announcement:

1) Technology visionaries like Dr. Goodnight are ideally positioned to help forge new data paths in heavily entrenched (or regulated) global industries like healthcare
2) As the global leader in analytics (with customers in 135 countries across 65,000 installations), SAS is strategically well positioned to deliver huge ROI across the healthcare ecosystem – at scale
3) Collaboration and transparency – especially around big data – is an enormous challenge for healthcare around security and privacy – but an even bigger opportunity

The list is much longer, of course, but perhaps the biggest single takeaway is simply this – a key word search for the phrase “big pharma” with “data collaboration” will no longer result in the banner proclamation of “404 – Page Not Found.” 

image: Pharma/shutterstock


Original Post

 

TAGGED:big dataGSKpharmaSAS
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

5 Things Hospitals Can Learn About Patient Engagement From Netflix

October 16, 2015

Waste in the American Health Care System?

September 7, 2012
Hospital Marketing, Patient Engagement
BusinessHospital Administration

How to Build Realistic Patient Expectations with Hospital Marketing

September 24, 2014
social media healthcare
eHealthSocial Media

Five Uses of Social Media to Create Relationships with Your Patients

September 20, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?